Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper.

O, Pfaar; P, Demoly; van Wijk R, Gerth; S, Bonini; J, Bousquet; GW, Canonica; SR, Durham; L, Jacobsen; HJ, Malling; R, Mösges; NG, Papadopoulos; S, Rak; del Rio P, Rodriguez; E, Valovirta; U, Wahn; MA, Calderon

doi:10.1111/all.12383

Public

Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper.

Shared by NobleBlocks on Apr 25, 2014 • 12:00 AM UTC

Authors:

Pfaar O

Demoly P

Gerth van Wijk R

Abstract

Background Allergen immunotherapy (AIT) has been thoroughly documented in randomized controlled trials (RCTs). It is the only immune-modifying and causal treatment available for patients suffering from IgE-mediated diseases such as allergic rhinoconjunctivitis, allergic asthma and insect sting aller...

Subject

Randomized controlled trials

Clinical Outcomes

Allergen Immunotherapy

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!